Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Adrian T. Kress"'
Autor:
Martin O. Evans, Darren M. Smith, Adrian T. Kress, Robert J. Nadeau, Daniel J. Selig, Diana Caridha, Ratanachat Racharaks, Thomas Langowski, Michael S. Madejczyk, Chance Carbaugh, David Saunders, Mark Widder, Jason De Meese, Patricia J. Lee, Jesse P. DeLuca
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 7, Pp n/a-n/a (2024)
Abstract Plerixafor is a CXCR4 antagonist approved in 2008 by the FDA for hematopoietic stem cell collection. Subsequently, plerixafor has shown promise as a potential pathogen‐agnostic immunomodulator in a variety of preclinical animal models. Add
Externí odkaz:
https://doaj.org/article/e1f253fa61f04f4a85dd315fe4e40e06
Autor:
Jonathan D. Vignali, Kevin C. Pak, Holly R. Beverley, Jesse P. DeLuca, John W. Downs, Adrian T. Kress, Brett W. Sadowski, Daniel J. Selig
Publikováno v:
Journal of Xenobiotics, Vol 13, Iss 2, Pp 218-236 (2023)
Selective Androgen Receptor Modulators (SARMs) are not FDA approved, and obtaining SARMs for personal use is illegal. Nevertheless, SARM use is increasingly popular amongst recreational athletes. Recent case reports of drug-induced liver injury (DILI
Externí odkaz:
https://doaj.org/article/170c10edb2494686ace877a092c3032d
Autor:
David A. Kerling, Sarah C. Clarke, Jesse P. DeLuca, Martin O. Evans, Adrian T. Kress, Robert J. Nadeau, Daniel J. Selig
Publikováno v:
Pharmaceutics, Vol 15, Iss 5, p 1411 (2023)
Loop diuretics and antibiotics are commonly co-prescribed across many clinical care settings. Loop diuretics may alter antibiotic pharmacokinetics (PK) via several potential drug interactions. A systematic review of the literature was performed to in
Externí odkaz:
https://doaj.org/article/c6f3b54ef83f476eb99186ef843b6c09
Publikováno v:
Antibiotics, Vol 12, Iss 3, p 444 (2023)
Introduction: Probability of target attainment (PTA) analysis using Monte Carlo simulations has become a mainstay of dose optimization. We highlight the technical and clinical factors that may affect PTA for beta-lactams. Methods: We performed a mini
Externí odkaz:
https://doaj.org/article/fe82a16df2734ad1856b1855cccc3952
Autor:
Daniel J. Selig, Kevin S. Akers, Kevin K. Chung, Adrian T. Kress, Jeffrey R. Livezey, Elaine D. Por, Kaitlin A. Pruskowski, Jesse P. DeLuca
Publikováno v:
Antibiotics, Vol 11, Iss 5, p 618 (2022)
Critical illness caused by burn and sepsis is associated with pathophysiologic changes that may result in the alteration of pharmacokinetics (PK) of antibiotics. However, it is unclear if one mechanism of critical illness alters PK more significantly
Externí odkaz:
https://doaj.org/article/87aa22adf20b46ba96bfbd205b5f2b80
Autor:
Daniel J. Selig, Tyler Reed, Kevin K. Chung, Adrian T. Kress, Ian J. Stewart, Jesse P. DeLuca
Publikováno v:
Blood Purification. 52:25-31
Introduction: The Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100) is a hemoperfusion device that can remove pathogens from central circulation. However, the effect of Seraph 100 on achieving pharmacodynamic (PD) targets is not well descri
Autor:
Daniel J. Selig, Adrian T. Kress, Isaiah M. Horton, Jeffrey R. Livezey, Eliot J. Sadik, Jesse P. DeLuca
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 47:1122-1133
Osteoarthritis (OA) is a common cause of joint disease and activity limitation in adults. Common therapies to treat OA-related pain are oral and topical non-steroidal anti-inflammatory drugs (NSAIDs) and intra-articular (IA) corticosteroids. However,
Autor:
Daniel J Selig, Jeffrey R Livezey, Geoffrey C Chin, Jesse P DeLuca, Walter O Guillory II, Adrian T Kress, Thomas O Oliver, Elaine D Por
Publikováno v:
Military Medicine. 187:9-17
Introduction Clinical utilization of pharmacogenomics (PGx) testing is highly institutionally dependent, and little information is known about provider practices of PGx testing in the Military Health System (MHS). In this study, we aimed to character
Autor:
Jeffrey R. Livezey, Thomas Oliver, Daniel J. Selig, Elaine D. Por, Jesse P. DeLuca, Adrian T. Kress, Rosenie Thelus Jean, Aaron J. Brown
Publikováno v:
Pharmacoepidemiology and Drug Safety. 29:1605-1615
PURPOSE To explore patterns of antimuscarinic medication as a risk factor for type 2 diabetes mellitus (T2DM). METHODS This is a retrospective cohort study of females 18 years or older within the Military Health System from 2006 to 2016. Administrati
Autor:
April K. Kathcart, C. K. Lee, Daniel Emerling, R. Weltzin, Aziz N. Qabar, Wayne Volkmuth, Kevin Hauns, Silas A. Davidson, Charles Magee, Erik Jongert, Jack Komisar, Susan Cicatelli, Johan Vekemans, Ulrike Wille-Reece, Norman C. Waters, Adrian T. Kress, Danielle Morelle, Jason W. Bennett, Marc Lievens, Matthew E. Griffith, Joe Cohen, Jason A. Regules, Paige E. Waterman, Jeffrey R. Livezey, Robert Paris, Ashley J. Birkett, Christian F. Ockenhouse, Sheetij Dutta, Bebi Yassin-Rajkumar, James E. Moon, W. Ripley Ballou, Mariusz Wojnarski, David C. Kaslow, Kristopher M. Paolino, Patrick S. Twomey, William H. Robinson
Publikováno v:
Journal of Infectious Diseases. 214:762-771
BACKGROUND Three full doses of RTS,S/AS01 malaria vaccine provides partial protection against controlled human malaria parasite infection (CHMI) and natural exposure. Immunization regimens, including a delayed fractional third dose, were assessed for